http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005108432-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff524f021138ed6e1b648a5161cbb322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_576efaa251e26bfc3508bd6e67f16bd2
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2299-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
filingDate 2005-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f5488e49d9930b2d92ae732be9e32a5
publicationDate 2006-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005108432-A3
titleOfInvention Cd80 (b7-1) binding peptides and uses thereof
abstract Molecules that bind the CD80 (B7-1) ligand presented by Antigen Presenting Cells and thereby selectively inhibit costimulation of T cells. Various forms and preparations of these molecules may bind to the CD80 ligand under either or both in vivo or in vitro conditions. These molecules may be referred to as pseudo-receptors include polypeptides include polypeptides that incorporate the amino-acid sequence MQPPGC, and a retro-inverso peptide mimic that includes the D-amino acid sequence CGPPQM. These molecules have a propensity to adopt a polyproline type II helical conformation under physiological conditions. Uses for these molecules include studying the immune system, screening for other compounds that affect the immune system, or at least components of the immune system, and the treatment of autoimmune diseases such as multiple sclerosis, colitis (inflammatory bowel disease -IBD), rheumatoid arthritis, Crohn's disease, Sjorgren's syndrome, diabetes mellitus, and solid tissue transplant rejection.
priorityDate 2004-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003091593-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003147905-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20055127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396401

Total number of triples: 22.